Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



A Study of miRNA 371 in Patients with Germ Cell Tumors

Urologic

This trial studies whether the blood marker micro ribonucleic acid (miRNA) 371 can predict the chance of cancer returning in patients with germ cell cancers. Studying samples of blood from patients with germ cell cancers in the laboratory may help doctors predict how likely the cancer will come back.
Urologic
N/A
Davis, Nancy
NCT04435756
ECOGUROS1823

Genetic Testing in Screening Patients with Metastatic or Unresectable Colon or Rectal Cancer for a COLOMATE Trial

Multiple Cancer Types

This trial screens patients with colon or rectal cancer that has spread to other places in the body (metastatic) or cannot be removed by surgery (unresectable) for genetic mutations for recommendation to a molecularly assigned therapy. Identifying gene mutations may help patients enroll onto target companion trials that target these mutations.
Colon, Rectal
N/A
Ciombor, Kristen
NCT03765736
VICCGI2011

Long Term Follow-up for Early Detection of Lung Cancer in Current or Former Smokers

Lung

This research trial studies the long term follow-up for early detection of lung cancer in current or former smokers. Following up on smokers by collecting and analyzing specimens in the laboratory, performing chest computed tomography (CT) scans, as well as reviewing medical records may help doctors detect lung cancer at an earlier stage.
Lung
N/A
Massion, Pierre
NCT03181256
VICCTHO1730

Artificial Tears for the Reduction of Radioiodine Levels in the Nasolacrimal Duct System of Patients with Thyroid Carcinoma following Radioiodine Therapy

Head/Neck

This phase II trial studies how well artificial tears works in reducing radioiodine levels in the nasolacrimal duct system in patients with thyroid carcinoma following radioiodine therapy. Radioactive iodine therapy for thyroid carcinoma has been associated with nasolacrimal duct obstruction. Artificial tears may dilute the amount of radioactive iodine in the tears of the eyes, thus decreasing uptake by the cells lining the nasolacrimal duct system.
Head/Neck
II
Sobel, Rachel
NCT04327999
VICCHN2018

A Phase 2 Study of Cabozantinib in combination with Atezolizumab as Neoadjuvant Treatment for muscle-invasive Bladder Cancer (ABATE)

Bladder

Bladder
II
Davis, Nancy
NCT04289779
VICCURO2044

Wren Melanoma Study

Melanoma

Melanoma
N/A
Kauffmann, Rondi
NCT03267381
VICCMEL1783

Identifying Predictors of Poor Health-Related Quality-of-Life among Pediatric Hematopoietic Stem Cell Donors.

Pediatrics

Pediatrics
N/A
Kitko, Carrie
NCT03718546
VICCPED1949

The COVID-19 and Cancer Consortium (CCC19) Registry

Miscellaneous

Miscellaneous
N/A
Warner, Jeremy
NCT04354701
VICCMD2032

Molecular Predictors of Lung Cancer Behavior. (SPORE)

Multiple Cancer Types

Lung, Non Small Cell, Small Cell
N/A
Massion, Pierre
NCT00898313
VICCTHO0398

Islet Cell and ST2 Axis Dysregulation in Post-Transplant Diabetes Mellitus

Not Available
N/A
Engelhardt, Brian
NCT03415139
VICCCTT1836

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: